Influenza Human
📧 Sign up to get email alerts when something new happens for Influenza Human.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Update: A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age [Phase 3]
A Phase 3 study assessing the efficacy, safety, and immunogenicity of an adjuvanted influenza vaccine versus a non-adjuvanted influenza vacc…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine [Phase 2]
Phase 2 dose-ranging pediatric trial of an adjuvanted pandemic influenza vaccine completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures [Phase 4]
Phase 4 clinical trial exploring how repeated exposures to influenza vaccination affect immune responses.
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong [Phase 4]
Phase 4 trial update evaluating the immunogenicity of twice-annual influenza vaccination in older adults in Hong Kong.
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed [Phase 2]
Phase 2 clinical trial evaluating safety and immunogenicity of one or two booster doses of an H5N6 influenza vaccine in adults previously pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of XC8 40 mg film-coated tablets for dry non-productive cough associated with acute respi…
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection [Phase 2]
Phase 2 trial update on XC8 10 mg film-coated tablets for dry non-productive cough associated with acute respiratory viral infection; study …
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates [NA]
Completed clinical trial evaluating behavioral science strategies to increase flu-shot rates; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17. [Phase 3]
Phase 3 trial comparing a recombinant quadrivalent influenza vaccine to a marketed quadrivalent in children aged 3 to 17 has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Treatment of Severe Influenza A Infection [Phase 3]
A Phase 3 clinical trial update on treating severe influenza A infection has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: A Pharmacokinetics Study of Favipiravir in Patients With Severe Influenza [Phase 2]
Phase 2 pharmacokinetics study of favipiravir in patients with severe influenza has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Reactogenicity, Safety and Immunogenicity Study of a Allantoic Split Inactivated Seasonal Influenza Vaccine [Phase 1]
This document reports the completion of a Phase 1 trial evaluating reactogenicity, safety, and immunogenicity of an allantoic split inactiva…
-
CLINICAL_TRIALS trial_result · 2011-03-04Clinical Trial Update: Prophylactic Efficacy of Relenza Against Influenza A and B
Completed clinical trial results evaluating whether Relenza (zanamivir) can prevent influenza A and B infections.